Bioorganic & Medicinal Chemistry Letters · 2012 · 35 citations · 14 references
PharmacyMedicinal ChemistryOncologyDrug DesignDrug DiscoveryLead OptimizationHit-to-lead OptimizationHit-to-lead ProgressionLead Compound DesignLead DiscoveryLead Compound PrioritizationMolecular Property OptimizationStructure-based Lead DiscoveryStructure-guided Lead Discovery
14
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations
Medicine, Oncology, Pharmacology +15
Mdm2 promotes the rapid degradation of p53
Ygal Haupt, Ruth Maya, Anat Kazaz et al. · Nature · 1997 · 4.5K citations
Regulation of p53 stability by Mdm2
Michael H.G. Kubbutat, Stephen N. Jones, Karen H. Vousden · Nature · 1997 · 3.3K citations
Database of p53 gene somatic mutations in human tumors and cell lines.
Monica Hollstein, Kevin P. Rice, Marc S. Greenblatt et al. · PubMed · 1994 · 863 citations